New Key Statistics Module, Z-Score and F-Score
NAS:RARE Key Ratios
| Market Cap $ M | 5,230.38 |
| Enterprise Value $ M | 4,504.01 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 12.00 |
| Price/Sales | 9.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 481.00 |
| EPS (TTM) $ | -7.30 |
| Beneish M-Score | -2.37 |
| 10-y EBITDA Growth Rate % | -14.30 |
| 5-y EBITDA Growth Rate % | -16.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -8.59 |
| EV-to-EBITDA | -9.17 |
| PEG | -- |
| Shares Outstanding M | 92.17 |
| Net Margin (%) | -121.57 |
| Operating Margin % | -114.04 |
| Pre-tax Margin (%) | -121.93 |
| Quick Ratio | 3.39 |
| Current Ratio | 3.54 |
| ROA % (ttm) | -42.00 |
| ROE % (ttm) | -290.00 |
| ROIC % (ttm) | -75.33 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.82 |
RARE Number of Guru Trades
RARE Volume of Guru Trades
Gurus Latest Trades with NAS:RARE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RARE is held by these investors
Total 1
Ultragenyx Pharmaceutical Inc Insider Transactions
No Available Data
News about NAS:RARE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers